The effect of empagliflozin on diuresis and neurohumoral factors in the patients with decompensated heart failure and diabetes mellitus: pilot study
Not Applicable
- Conditions
- decompensated heaat failure type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000027431
- Lead Sponsor
- Department of Cardiology, National Hospital Organization Yokohama Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient who has contraindication for empagliflozin administration 2. Patient who is in shock at registeration 3. Patient who is undergone or required intra-aortic balloon pumping (IABP), percutaneous cardiopulmonary support (PCPS) and/or dialysis at registration 4. Patient who cannot be obtained informed consent 5. Patient who is judged as unsuitable for this study by attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rine output during a day
- Secondary Outcome Measures
Name Time Method amount of furosemide injection intravenously Holter electrocardiography Echocardiography neurohumoral factors